AKT1 and lung cancer: The PI3K/AKT pathway is associated with drug resistance, apoptosis, proliferation, metastasis, and invasion in lung cancer(Gong et al. 2022; Guan et al. 2021; Liu et al. 2020; Xiong et al. 2022).